Bank of America’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194 | Sell |
324
-13,392
| -98% | -$8.02K | ﹤0.01% | 6805 |
|
|
2025
Q1 | $3.7K | Sell |
13,716
-192,941
| -93% | -$52.1K | ﹤0.01% | 6215 |
|
|
2024
Q4 | $107K | Sell |
206,657
-1
| -0% | -$1 | ﹤0.01% | 5492 |
|
|
2024
Q3 | $670K | Sell |
206,658
-1,311
| -0.6% | -$4.25K | ﹤0.01% | 4502 |
|
|
2024
Q2 | $624K | Sell |
207,969
-2,607
| -1% | -$7.82K | ﹤0.01% | 4453 |
|
|
2024
Q1 | $979K | Sell |
210,576
-55
| -0% | -$256 | ﹤0.01% | 4179 |
|
|
2023
Q4 | $872K | Sell |
210,631
-2,904
| -1% | -$12K | ﹤0.01% | 4232 |
|
|
2023
Q3 | $641K | Sell |
213,535
-23,366
| -10% | -$70.1K | ﹤0.01% | 4331 |
|
|
2023
Q2 | $583K | Buy |
236,901
+199,567
| +535% | +$491K | ﹤0.01% | 4385 |
|
|
2023
Q1 | $84.4K | Buy |
37,334
+20,774
| +125% | +$46.9K | ﹤0.01% | 5518 |
|
|
2022
Q4 | $57.8K | Buy |
16,560
+2,695
| +19% | +$9.41K | ﹤0.01% | 5658 |
|
|
2022
Q3 | $513K | Buy |
13,865
+5,078
| +58% | +$188K | ﹤0.01% | 4641 |
|
|
2022
Q2 | $167K | Buy |
8,787
+2,051
| +30% | +$39K | ﹤0.01% | 5453 |
|
|
2022
Q1 | $182K | Sell |
6,736
-3,670
| -35% | -$99.2K | ﹤0.01% | 5766 |
|
|
2021
Q4 | $235K | Sell |
10,406
-1,875
| -15% | -$42.3K | ﹤0.01% | 5605 |
|
|
2021
Q3 | $322K | Buy |
12,281
+6,084
| +98% | +$160K | ﹤0.01% | 5148 |
|
|
2021
Q2 | $199K | Sell |
6,197
-1,581
| -20% | -$50.8K | ﹤0.01% | 5336 |
|
|
2021
Q1 | $274K | Buy |
7,778
+1,970
| +34% | +$69.4K | ﹤0.01% | 5164 |
|
|
2020
Q4 | $186K | Sell |
5,808
-1,751
| -23% | -$56.1K | ﹤0.01% | 4928 |
|
|
2020
Q3 | $284K | Sell |
7,559
-1,242
| -14% | -$46.7K | ﹤0.01% | 4491 |
|
|
2020
Q2 | $394K | Sell |
8,801
-5,161
| -37% | -$231K | ﹤0.01% | 4271 |
|
|
2020
Q1 | $476K | Buy |
+13,962
| New | +$476K | ﹤0.01% | 4023 |
|